Although an early study reported that administration of rhIL-7 following adoptive immunotherapy led to enhanced antitumor effects in a colon carcinoma xenograft model52, the use of IL-7 as an adjuvant for ACT has not been extensively pursued. Here, IL7 is linked to colon carcinoma.